Literature DB >> 27374637

Immune responses and immunopathology in acute and chronic viral hepatitis.

Eui-Cheol Shin1, Pil Soo Sung1,2, Su-Hyung Park3.   

Abstract

Hepatitis A virus (HAV), hepatitis B virus (HBV) and hepatitis C virus (HCV) are responsible for most cases of viral hepatitis. Infection by each type of virus results in a different typical natural disease course and clinical outcome that are determined by virological and immunological factors. HCV tends to establish a chronic persistent infection, whereas HAV does not. HBV is effectively controlled in adults, although it persists for a lifetime after neonatal infection. In this Review, we discuss the similarities and differences in immune responses to and immunopathogenesis of HAV, HBV and HCV infections, which may explain the distinct courses and outcomes of each hepatitis virus infection.

Entities:  

Mesh：

Substances：

Year:  2016        PMID： 27374637     DOI： 10.1038/nri.2016.69

Source DB:  PubMed          Journal:  Nat Rev Immunol        ISSN： 1474-1733            Impact factor:   53.106


  177 in total

Review 1.  Stealth and cunning: hepatitis B and hepatitis C viruses.

Authors:  Stefan F Wieland; Francis V Chisari
Journal:  J Virol       Date:  2005-08       Impact factor: 5.103

Review 2.  Hepatitis A virus: from discovery to vaccines.

Authors:  Annette Martin; Stanley M Lemon
Journal:  Hepatology       Date:  2006-02       Impact factor: 17.425

Review 3.  Hepatitis B virus infection.

Authors:  Christian Trépo; Henry L Y Chan; Anna Lok
Journal:  Lancet       Date:  2014-06-18       Impact factor: 79.321

4.  Restoration of HBV-specific CD8+ T cell function by PD-1 blockade in inactive carrier patients is linked to T cell differentiation.

Authors:  Bertram Bengsch; Bianca Martin; Robert Thimme
Journal:  J Hepatol       Date:  2014-07-10       Impact factor: 25.083

5.  Successful vaccination induces multifunctional memory T-cell precursors associated with early control of hepatitis C virus.

Authors:  Su-Hyung Park; Eui-Cheol Shin; Stefania Capone; Laura Caggiari; Valli De Re; Alfredo Nicosia; Antonella Folgori; Barbara Rehermann
Journal:  Gastroenterology       Date:  2012-06-13       Impact factor: 22.682

Review 6.  Current progress in development of hepatitis C virus vaccines.

Authors:  T Jake Liang
Journal:  Nat Med       Date:  2013-07       Impact factor: 53.440

7.  Acute hepatitis A virus infection is associated with a limited type I interferon response and persistence of intrahepatic viral RNA.

Authors:  Robert E Lanford; Zongdi Feng; Deborah Chavez; Bernadette Guerra; Kathleen M Brasky; Yan Zhou; Daisuke Yamane; Alan S Perelson; Christopher M Walker; Stanley M Lemon
Journal:  Proc Natl Acad Sci U S A       Date:  2011-06-20       Impact factor: 11.205

8.  T cells with a CD4+CD25+ regulatory phenotype suppress in vitro proliferation of virus-specific CD8+ T cells during chronic hepatitis C virus infection.

Authors:  Tobias Boettler; Hans Christian Spangenberg; Christoph Neumann-Haefelin; Elisabeth Panther; Simonetta Urbani; Carlo Ferrari; Hubert E Blum; Fritz von Weizsäcker; Robert Thimme
Journal:  J Virol       Date:  2005-06       Impact factor: 5.103

9.  Natural killer cells are polarized toward cytotoxicity in chronic hepatitis C in an interferon-alfa-dependent manner.

Authors:  Golo Ahlenstiel; Rachel H Titerence; Christopher Koh; Birgit Edlich; Jordan J Feld; Yaron Rotman; Marc G Ghany; Jay H Hoofnagle; T Jake Liang; Theo Heller; Barbara Rehermann
Journal:  Gastroenterology       Date:  2009-09-10       Impact factor: 22.682

10.  Analysis of successful immune responses in persons infected with hepatitis C virus.

Authors:  F Lechner; D K Wong; P R Dunbar; R Chapman; R T Chung; P Dohrenwend; G Robbins; R Phillips; P Klenerman; B D Walker
Journal:  J Exp Med       Date:  2000-05-01       Impact factor: 14.307
View more
  98 in total

1.  TLR9-Mediated Conditioning of Liver Environment Is Essential for Successful Intrahepatic Immunotherapy and Effective Memory Recall.

Authors:  Marcin Cebula; Mathias Riehn; Upneet Hillebrand; Ramona F Kratzer; Florian Kreppel; Georgia Koutsoumpli; Toos Daemen; Hansjörg Hauser; Dagmar Wirth
Journal:  Mol Ther       Date:  2017-07-14       Impact factor: 11.454

2.  18F-FAC PET Selectively Images Liver-Infiltrating CD4 and CD8 T Cells in a Mouse Model of Autoimmune Hepatitis.

Authors:  Jessica R Salas; Bao Ying Chen; Alicia Wong; Donghui Cheng; John S Van Arnam; Owen N Witte; Peter M Clark
Journal:  J Nucl Med       Date:  2018-04-26       Impact factor: 10.057

3.  IL-33 induces immunosuppressive neutrophils via a type 2 innate lymphoid cell/IL-13/STAT6 axis and protects the liver against injury in LCMV infection-induced viral hepatitis.

Authors:  Yuejin Liang; Panpan Yi; Denley Ming Kee Yuan; Zuliang Jie; Zakari Kwota; Lynn Soong; Yingzi Cong; Jiaren Sun
Journal:  Cell Mol Immunol       Date:  2018-02-05       Impact factor: 11.530

Review 4.  Hepatitis B reactivation during or after direct acting antiviral therapy - implication for susceptible individuals.

Authors:  Jacinta A Holmes; Ming-Lung Yu; Raymond T Chung
Journal:  Expert Opin Drug Saf       Date:  2017-05-19       Impact factor: 4.250

5.  Effects of transarterial chemoembolization on regulatory T cell and its subpopulations in patients with hepatocellular carcinoma.

Authors:  Hana Park; Jae Hyung Jung; Min Kyung Jung; Eui-Cheol Shin; Simon Weonsang Ro; Jeon Han Park; Do Young Kim; Jun Yong Park; Kwang-Hyub Han
Journal:  Hepatol Int       Date:  2020-02-18       Impact factor: 6.047

6.  Genotype-related variations in proinflammatory and regulatory cytokine levels in treated and treatment-naive HCV-infected patients.

Authors:  Rasoul Baharlou; Bizhan Romani; Seyed Jalal Kiani; Kaveh Sadeghi; Enayatollah Shadmand; Hadi Fazel; Farid Azizi Jalilian; Ebrahim Kord; Sajad Yaghoubi; Yousef Nikmanesh; Abbas Ahmadi Vasmehjani
Journal:  Med Microbiol Immunol       Date:  2017-11-17       Impact factor: 3.402

Review 7.  Mechanisms of Hepatitis B Virus Persistence.

Authors:  Kuen-Nan Tsai; Cheng-Fu Kuo; Jing-Hsiung James Ou
Journal:  Trends Microbiol       Date:  2017-08-16       Impact factor: 17.079

8.  Tumor Necrosis Factor-producing T-regulatory Cells Are Associated With Severe Liver Injury in Patients With Acute Hepatitis A.

Authors:  Yoon Seok Choi; Min Kyung Jung; Jeewon Lee; Seong Jin Choi; Sung Hoon Choi; Hyun Woong Lee; Jong-Joo Lee; Hyung Joon Kim; Sang Hoon Ahn; Dong Hyeon Lee; Won Kim; Su-Hyung Park; Jun R Huh; Hyoung-Pyo Kim; Jun Yong Park; Eui-Cheol Shin
Journal:  Gastroenterology       Date:  2017-12-09       Impact factor: 22.682

Review 9.  Natural killer cells in hepatocellular carcinoma: current status and perspectives for future immunotherapeutic approaches.

Authors:  Min Yu; Zonghai Li
Journal:  Front Med       Date:  2017-08-05       Impact factor: 4.592

10.  Impaired immune cell cytotoxicity in severe COVID-19 is IL-6 dependent.

Authors:  Alessio Mazzoni; Lorenzo Salvati; Laura Maggi; Manuela Capone; Anna Vanni; Michele Spinicci; Jessica Mencarini; Roberto Caporale; Benedetta Peruzzi; Alberto Antonelli; Michele Trotta; Lorenzo Zammarchi; Luca Ciani; Leonardo Gori; Chiara Lazzeri; Andrea Matucci; Alessandra Vultaggio; Oliviero Rossi; Fabio Almerigogna; Paola Parronchi; Paolo Fontanari; Federico Lavorini; Adriano Peris; Gian Maria Rossolini; Alessandro Bartoloni; Sergio Romagnani; Francesco Liotta; Francesco Annunziato; Lorenzo Cosmi
Journal:  J Clin Invest       Date:  2020-09-01       Impact factor: 14.808
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.